Table 2 Primary and secondary outcomes at baseline and follow-up, by study arm
| Â | Current modern family planning use, non-pregnant women only | Experience of IPV within past 12Â months | ||||||
|---|---|---|---|---|---|---|---|---|
Baseline n (%) | p-valuea | Follow-up n (%) | p-valuea | Baseline n (%) | p-valuea | Follow-up n (%) | p-valuea | |
N (adolescent wives) | 933 | Â | 843 | Â | 1050 | Â | 957 | Â |
Overall | 110 (11.8%) | Â | 323 (38.3%) | Â | 93 (8.9%) | Â | 94 (9.8%) | Â |
Treatment status | Â | 0.01 | Â | 0.002 | Â | 0.21 | Â | 0.26 |
 Control | 37 (17.0%) |  | 61 (29.2%) |  | 18 (6.9%) |  | 28 (11.7%) |  |
 Intervention | 73 (10.2%) |  | 262 (41.3%) |  | 75 (9.5%) |  | 66 (9.2%) |  |
Study arm |  | < 0.001 |  | 0.01 |  | < 0.001 |  | 0.31 |
 Control | 37 (17.0%) |  | 61 (29.2%) |  | 18 (6.9%) |  | 28 (11.7%) |  |
 Arm 1—home visits only | 16 (6.3%) |  | 88 (40.0%) |  | 11 (3.9%) |  | 23 (9.0%) |  |
 Arm 2—group sessions only | 38 (17.1%) |  | 80 (40.4%) |  | 26 (10.6%) |  | 16 (7.2%) |  |
 Arm 3—home visits and group sessions | 19 (8.0%) |  | 94 (43.5%) |  | 38 (14.6%) |  | 27 (11.3%) |  |